NDA-Enabling Study Fact Sheet Available!


NDA-Enabling Studies

The development of an NDA submission plan can sometimes be unclear. Partnering with the right CRO early on can increase your chances of success and ensure you meet your milestones. With over 25 years of experiences, Altasciences' specialists apply their knowledge in designing, conducting, analyzing, and reporting on trials for regulatory submissions, across the spectrum of therapeutic areas. 

Our complimentary fact sheet guides you through the different study types and features of NDA-enabling clinical pharmacology studies, and how we can support you.

Download fact sheet now

Want to learn more about some of the requirements for each study? Click on the links below: 

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.